首页> 外文期刊>British Journal of Haematology >Serological response to SARS‐CoV‐2 mRNA‐containing lipid nanoparticle vaccine in patients with multiple myeloma: A negative impact of CD38+ regulatory T cells?
【24h】

Serological response to SARS‐CoV‐2 mRNA‐containing lipid nanoparticle vaccine in patients with multiple myeloma: A negative impact of CD38+ regulatory T cells?

机译:Serological response to SARS‐CoV‐2 mRNA‐containing lipid nanoparticle vaccine in patients with multiple myeloma: A negative impact of CD38+ regulatory T cells?

获取原文
获取原文并翻译 | 示例
       

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号